Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours

Nature Genetics

Volumn 10, Issue 4, 1995, Pages 436-444

  Schoenmakers, Eric F P M ^a   Wanschura, Sylke ^b   Mols, Raf ^a   Bullerdiek, Jörn ^b   Berghe, Herman Vanden ^a   van de Ven, Wim J M ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF BREMEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; HIGH MOBILITY GROUP PROTEIN;

ARTICLE; CHROMOSOME 12Q; CHROMOSOME ABERRATION; CHROMOSOME BREAKAGE; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE MAPPING; GENE REARRANGEMENT; HUMAN; HUMAN CELL; MESENCHYMOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SOLID TUMOR; SOUTHERN BLOTTING;

BASE SEQUENCE; CHROMOSOMES, HUMAN, PAIR 12; DNA PRIMERS; GENE REARRANGEMENT; HIGH MOBILITY GROUP PROTEINS; HMGA2 PROTEIN; HUMAN; IN SITU HYBRIDIZATION, FLUORESCENCE; MESODERM; MOLECULAR SEQUENCE DATA; NEOPLASMS; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0029088063     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng0895-436     Document Type: Article

References (39)

1. Mitelman, F. Catalog of chromosome aberrations in cancer. 4th ed., New York, Wiley-Liss (1994).
2. Turc-Carel, C. et al. Cytogenetic studies of adipose tissue tumors. II. Recurrent reciprocal translocation t(12; 16)(q13; p11) in myxoid liposarcomas. Cancer Genet. Cytogenet. 23, 291-299 (1986).
3. Fletcher, J. A. Translocation (12; 22)(q13-14q12) is a nonrandom aberration in soft-tissue clear-cell sarcoma. Genes Chrom. Cancer 5, 184 (1992).
4. Roberts, P. et al. 12q13 Abnormality in rhabdomyosarcoma. A nonrandom Occurrence? Cancer Genet. Cytogenet. 60, 135-140 (1992).
5. Aman, P. et al. Rearrangement of the transcription factor gene CHOP in myxoid liposarcomas with t(12; 16)(q13; p11). Genes Chrom. Cancer 5, 278-285 (1992).
6. Rabbitts, T. H., Forster, A., Larson, R. & Nathan, P. Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12; 16) in malignant liposarcoma. Nature Genet. 4, 175-180 (1993).
7. Zucman, J. et al. EWS and ATF-1 gene fusion induced by t(12; 22) translocation in malignant melanoma of soft parts. Nature Genet. 4, 341-345 (1993).
8. Van de Ven, W. J. M. et al. Molecular characterization of MAR, a multiple aberration region on human chromosome segment 12q13-q15 implicated in various solid tumors. Genes Chrom. Cancer 12, 296-303 (1995).
9. Cramer, D. W. Epidemiology of myomas. Semin. Repro. Endocrinol. 10, 320-324 (1992).
10. Schoenmakers, E. F. P. M. et al. Physical mapping of chromosome 12q breakpoints in lipoma, pleomorphic salivary gland adenoma, uterine leiomyoma, and myxoid liposarcoma. Genomics 20, 210-222 (1994).
11. Schoenmakers, E. F. P. M. et al. Identification, molecular cloning and characterization of the chromosome 12 breakpoint cluster region of uterine leiomyomas. Genes Chrom. Cancer 11, 106-118 (1994).
12. Rohen, C. et al. The 12q aberration of a breast hamartoma maps within MAR. Genes Chrom. Cancer (in the press).
13. Schoenmakers, E. F. P. M. et al. A 6 Mb yeast artificial chromosome contig and long range physical map encompassing the region on chromosome 12q15 frequently rearranged in a variety of benign solid tumors. Genomics (in the press).
14. Kools, P. F. J. et al. Identification of the chromosome 12 translocation breakpoint region of a pleomorphic salivary gland adenoma with t(1; 12)(p22; q15) as the sole cytogenetic abnormality. Cancer Genet. Cytogenet. 79, 1-7 (1995).
15. Kievits, T. et al. Rapid subchromosomal localization of cosmids by nonradioactive in situ hybridization. Cytogenet. Cell Genet. 53, 134-136 (1990).
16. Smith, M. W., Holmsen, A. L., Wei, Y. H., Peterson, M. & Evans, G. A. Genomic sequence sampling: a strategy for high resolution sequence-based physical mapping of complex genomes. Nature Genetics 7, 40-47 (1994).
17. Altschul, S. F., Gish, W., Miller, W., Myers, E. W. & Lipman, D. J. Basic local alignment search tool. J. molec. Biol. 215, 403-410 (1990).
18. Patel, U. A. et al. Expression and cDNA cloning of human HMGI-C phosphoprotein. Biochem. Biophys. Res. Commun. 201, 63-70 (1994).
19. Bustin, M., Lehn, D. A. & Landsman, D. Structural features of the HMG chromosomal proteins and their genes. Biochim. Biophys. Acta 1049, 231-243 (1990).
20. Manfioletti, G. et al. cDNA cloning of the HMGI-C phosphoprotein, a nuclear protein associated with neoplastic and undifferentiated phenotypes. Nucl. Acids Res. 19, 6793-6797 (1991).
21. Wagner, M. J., Ge, Y., Siciliano, M. & Wells, D. E. A hybrid cell mapping panel for regional localization of probes to human chromsome 8. Genomics 10, 114-125 (1991).
22. Schoenberg Fejzo, M. et al. Identification of a YAC spanning the translocation breakpoints in uterine leiomyomata, pulmonary chondroid hamartoma and lipoma. Genomics 26, 265-275 (1995).
23. Friedman, M., Holth, L. T., Zoghbi, H. Y. & Reeves, R. Organization, inducible-expression and chromosome localization of the human HMG-I(Y) nonhistone protein gene. Nucl. Acids Res. 21, 4259-4267 (1993).
24. Rabbitts, T. H. Chromosomal translocations in human cancer. Nature 372, 143-149 (1994).
25. Yang-Yen, H. F. & Rothblum, L. I. Purification and characterization of a high-mobility-group-like DNA-binding protein that stimulates rRNA synthesis in vitro. Molec. cell. Biol. 8, 3406-3414 (1988).
26. Reeves, R., Langan, T. A. & Nissen, M. S. Phosphorylation of the DNA-binding domain of nonhistone high-mobility group I protein by cdc2 kinase: reduction of binding affinity. Proc. natn. Acad. Sci. U. S. A. 88, 1671-1675 (1991).
27. Thanos, D. & Maniatis, T. The high mobility group protein HMGI(Y) is required for NF-KB-dependent virus induction of the human IFN-gene. Cell 71, 777-789 (1992).
28. Du, W. & Maniatis, T. The high mobility group protein HMGI(Y) can stimulate or inhibit DNA binding of distinct transcriptional factor ATF-2 isoforms. Proc. natn. Acad. Sci. U. S. A. 91, 11318-11322 (1994).
29. Aizawa, S., Nishino, H., Saito, K., Kimura, K., Shirakawa, H. & Yoshida, M. Stimulation of transcription in cultured cells by high mobility group protein 1: Essential role of the acidic carboxy-terminal region. Biochemistry 33, 14690-14695 (1994).
30. Miles, H., Mcfarlane, J., Aleck, K. A. & Bawle, E. Macrocephaly with hamartomas: Bannayan-Zonana syndrome. Am. J. med. Genet. 19, 225-234 (1984).
31. Kazmierczak, B., Bartnitzke, S., Hartl, M. & Bullerdiek, J. In vitro transformation by the SV40 "early region" of cells from a human benign salivary gland tumor with a 12q13-q15 rearrangement. Cytogenet. Cell Genet. 53, 37-39 (1990).
32. Albertsen, H. M., Adderrahim, H., Cann, H. M., Dausset, J., Le Paslier, D. & Cohen, D. Construction and characterization of a yeast artificial chromosome library containing seven haploid human genome equivalents. Proc. natn. Acad. Sci. U. S. A. 87, 4256-4260 (1990).
33. Chumakov, I. et al. Continuum of overlapping clones spanning the entire human chromosome 21 q. Nature 359, 380-387 (1992).
34. Green, E. D. & Olson, M. V. Systematic screening of yeast artificial-chromosome libraries using the polymerase chain reaction. Proc. natn. Acad. Sci. U. S. A. 87, 1213-1217 (1990).
35. Montgomery, K. T. et al. Characterization of two chromosome 12 cosmid libraries and development of STSs from cosmids mapped by FISH. Genomics 17, 682-693 (1993).
36. Geurts, J. M. W., Schoenmakers, E. F. P. M., Mols, R. & Van de Ven, W. J. M. Improved procedure for rapid isolation and sequencing of DNA insert termini in yeast artificial chromosomes. Meth. molec. cell. Biol. 4, 257-265 (1994).
37. Nelson, D. L. et al. Alu polymerase chain reaction: A method for rapid isolation of human-specific sequences from complex DNA sources. Proc. natn. Acad. Sci. U. S. A. 86, 6686-6690 (1989).
38. Rychlik, W. & Rhoads, R. E. A computer program for choosing optimal oligonucleotides for filter hybridization, sequencing and in vitroamplification of DNA. Nucl. Acids Res. 17, 8543-8551 (1989).
39. Feinberg, A. P. & Vogelstein, B. A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132, 6-13 (1984).